Business Context and Reporting Period
This Form 6-K filing by CCH Holdings Ltd covers the month of August 2026. The report details significant changes to the Company's Board of Directors and executive leadership, effective August 5 and August 7, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
Resignations
- Wu Wai Kong: Resigned as independent director, chairperson of the Compensation Committee, and member of the Nominating and Corporate Governance and Audit Committees, effective August 5, 2026.
- Mhlengi Prevail Mafu: Resigned as director and co-chief executive officer, effective August 7, 2026.
- Chung Wai Wong: Resigned as director and member of the Nominating and Corporate Governance, Audit, and Compensation Committees, effective August 7, 2026.
The Board confirmed that none of these resignations resulted from disagreements regarding the Company's operations, policies, or practices.
Appointments
- Ms. Hsu Hui Chen: Appointed as director and co-chief executive officer, effective August 7, 2026. She brings extensive experience in global sourcing and procurement strategy from her tenure at Parexel International.
- Ms. Lim Fei Fern: Appointed as independent director, chairperson of the Compensation Committee, and member of the Audit and Nominating and Corporate Governance Committees, effective August 7, 2026. She is a certified finance professional with expertise in financial management and internal controls.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future performance, or specific risk factors. The appointments of the new directors have no specific term and may be terminated by either party at any time without advance notice.
Key Facts for Investor Verification
- Verify the strategic rationale behind the simultaneous departure of the co-CEO and two directors.
- Confirm the transition plan for the co-CEO role now held by Ms. Hsu Hui Chen.
- Review the biographical backgrounds of Ms. Hsu and Ms. Lim to assess their fit for the Company's specific operational needs.
- Check for any subsequent filings regarding the appointment of a replacement for Chung Wai Wong, as the text only mentions replacements for Mafu and Wu.